Cetuximab sarotalocan sodium, an antibody-photosensitive complex, combines Cetuximab, an epidermal growth factor receptor monoclonal antibody, with the dye IRdye700DX, a photosensitive substance. After administration, illumination with a red light at 690 nm [2] specifically destroys only the tumor cells.